Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: An immunocytochemical and in situ hybridization study

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 92, Issue 2, 2001, Pages 184-193

  Leong, Iona Tuling ^a,b   Fernandes, Bernard J ^a,b   Mock, David ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BZLF1 PROTEIN, HERPESVIRUS 4, HUMAN; DNA BINDING PROTEIN; EBNA 2 PROTEIN, HUMAN HERPESVIRUS 4; EBNA-2 PROTEIN, HUMAN HERPESVIRUS 4; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; EPSTEIN BARR VIRUS ANTIGEN; MATRIX PROTEIN; REPLICATION PROTEIN A; RPA1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; VIRUS ANTIGEN; VIRUS PROTEIN; VIRUS RNA;

ADULT; AGE; AGED; ARTICLE; B CELL LYMPHOMA; CHI SQUARE DISTRIBUTION; CLASSIFICATION; DNA REPLICATION; EPSTEIN BARR VIRUS; FEMALE; FOLLICULAR LYMPHOMA; GENETICS; HUMAN; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; MALE; MIDDLE AGED; MOUTH TUMOR; NONHODGKIN LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; STATISTICS; T CELL LYMPHOMA; VIROLOGY; VIRUS INFECTION; VIRUS LATENCY; VIRUS REPLICATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIGENS, VIRAL; CHI-SQUARE DISTRIBUTION; DNA REPLICATION; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; REPLICATION PROTEIN A; RNA, VIRAL; STATISTICS; TRANS-ACTIVATORS; VIRAL MATRIX PROTEINS; VIRAL PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0035432407     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2001.116155     Document Type: Article

References (61)

1. Baumforth KR, Young LS, Flavell KJ, Constandinou C, Murray PG. The Epstein-Barr virus and its association with human cancers. Mol Pathol 1999;52:307-22.
2. Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood 1992;80:8-20.
3. Purtilo DT, Strobach RS, Okano M, Davis JR. Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest 1992;67:5-23.
4. Tosato G, Taga K, Angiolillo AL, Sgadari C. Epstein-Barr virus as an agent of haematological disease. Baillieres Clin Haematol 1995;8:165-99.
5. Carbone A, Dolcetti R, Gloghini A, Maestro R, Vaccher E, di Luca D, et al. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study. Hum Pathol 1996;27:133-46.
6. Chan JK, Yip TT, Tsang WY, Ng CS, Lau WH, Poon YF, et al. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol 1994;18:938-46.
7. Guarner J, del Rio C, Carr D, Hendrix LE, Eley JW, Unger ER. Non-Hodgkin's lymphomas in patients with human immunodeficiency virus infection. Presence of Epstein-Barr virus by in situ hybridization, clinical presentation, and follow-up. Cancer 1991;68:2460-5.
8. de Bruin PC, Jiwa M, Oudejans JJ, van der Valk P, van Heerde P, Sabourin J-C, et al. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. Blood 1994;83:1612-8.
9. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, Karkov J, Black F, Skinhoj P, et al. AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am J Pathol 1991;138:149-63.
10. Hamilton-Dutoit SJ, Raphael M, Audouin J, Diebold J, Lisse I, Pedersen C, et al. In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood 1993;82:619-24.
11. Hummel M, Anagnostopoulos I, Korbjuhn P, Stein H. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types. J Pathol 1995;175:263-71.
12. Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciotto CG, Wahl R, et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 1988;318:733-41.
13. Kanavaros P, Briere J, Lescs MC, Gaulard P. Epstein-Barr virus in non-Hodgkin's lymphomas of the upper respiratory tract: association with sinonasal localization and expression of NK and/or T-cell antigens by tumour cells. J Pathol 1996:178;297-302.
14. Ott G, Kalla J, Ott MM, Muller-Hermelink HK. The Epstein-Barr virus in malignant non-Hodgkin's lymphoma of the upper aerodigestive tract. Diagn Mol Pathol 1997;6:134-9.
15. Ott G, Ott MM, Feller AC, Seidl S, Muller-Hermelink HK. Prevalence of Epstein-Barr virus DNA in different T-cell lymphoma entities in a European population. Int J Cancer 1992;51:562-7.
16. Pallesen G, Hamilton-Dutoit J, Rowe M, Lisse I, Ralfkiaer E, Sandvej K, et al. Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells. J Pathol 1991;165:289-99.
17. Shibata D, Weiss LM, Hernandez AM, Nathwani BN, Bernstein L, Levine AM. Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood 1993;81:2102-9.
18. Su IJ, Hsieh HC, Lin KH, Uen WC, Kao CL, Chen CJ, et al. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood 1991;77:799-808.
19. Tao Q, Ho FC, Loke SL, Srivastava G. Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type. Int J Cancer 1995;60:315-20.
20. Thomas JA, Cotter F, Hanby AM, Long LQ, Morgan PR, Bramble B, et al. Epstein-Barr virus-related oral T-cell lymphoma associated with human immunodeficiency virus immunosuppression. Blood 1993;81:3350-6.
21. Wutzler P, Farber I, Sauerbrei A, Helbig B, Wutke K, Rüdiger KD, et al. Demonstration of Epstein-Barr virus in malignant non-Hodgkin's lymphomas. Oncology 1986;43:224-9.
22. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986;47:883-9.
23. Gulley ML, Sargeant KP, Grider DJ, Eagan PA, Davey DD, Damm DD, et al. Lymphomas of the oral soft tissues are not preferentially associated with latent or replicative Epstein-Barr virus. Oral Surg Oral Med Oral Pathol Radiol Endod 1995;80:425-31.
24. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991;65:1107-15.
25. Fahraeus R, Rymo L, Rhim JS, Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 1990;345:447-9.
26. Young LS, Dawson CW, Eliopoulos AG. The expression and function of Epstein-Barr virus encoded latent genes. Mol Pathol 2000;53:238-47.
27. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985;43:831-40.
28. Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 1989;321:1080-5.
29. Klein G. Viral latency and transformation: the strategy of Epstein-Barr virus. Cell 1989;58:5-8.
30. Subar M, Neri A, Inghirami G, Knowles DM, Dalla-Favera R. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 1988;72:667-71.
31. Hamilton-Dutoit SJ, Pallesen G. A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas. Am J Pathol 1992;140:1315-25.
32. Katz BZ, Raab-Traub N, Miller G. Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. J Infect Dis 1989;160:589-98.
33. Korbjuhn P, Anagnostopoulos I, Hummel M, Tiemann M, Dallenbach F, Parwaresch MR, et al. Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas. Blood 1993;82:217-23.
34. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 1984;310:1225-30.
35. Green TL, Eversole LR. Oral lymphomas in HIV-infected patients: association with Epstein-Barr virus DNA. Oral Surg Oral Med Oral Pathol 1989;67:437-42.
36. Wolvius EB, Jiwa NM, van der Valk P, Horstman A, van der Waal I. Adenolymphoma and non-Hodgkin's lymphoma of the salivary glands and oral cavity in immunocompetent patients are not associated with latent Epstein-Barr virus. Oral Oncol 1997;33:119-23.
37. Gilligan K, Rajadurai P, Resnick L, Raab-Traub N. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sci USA 1990;87:8790-4.
38. Ambinder RF, Mann RB. Detection and characterization of Epstein-Barr virus in clinical specimens. Am J Pathol 1994;145:239-52.
39. Ambinder RF, Mann RB. Epstein-Barr-encoded RNA in situ hybridization: diagnostic applications. Hum Pathol 1994;25:602-5.
40. Gulley ML, Raab-Traub N. Detection of Epstein-Barr virus in human tissues by molecular genetic techniques. Arch Pathol Lab Med 1993;117:1115-20.
41. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
42. Lennert K, Feller AC. Histopathology of non-Hodgkin's lymphoma (based on the updated Kiel classification). 2nd ed. Berlin: Springer-Verlag; 1992.
43. Fukuda Y, Ishida T, Fujimoto M, Ueda T, Aozasa K. Malignant lymphoma of the oral cavity: clinicopathologic analysis of 20 cases. J Oral Pathol 1987;16:8-12.
44. Handlers JP, Howell RE, Abrams AM, Melrose RJ. Extranodal oral lymphoma. Part I. A morphologic and immunoperoxidase study of 34 cases. Oral Surg Oral Med Oral Pathol 1986;61:362-7.
45. Nadimi H. Subclasses of extranodal oral B-cell lymphomas express cIgM, plasmacytoid, and monocytoid differentiation. A study of 10 cases. Oral Surg Oral Med Oral Pathol 1994; 77:392-7.
46. Takahashi H, Fujita S, Okabe H, Tsuda N, Tezuka F. Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity. Pathol Res Pract 1993;189:300-11.
47. Regezi JA, Zarbo RJ, Stewart JC. Extranodal oral lymphomas: histologic subtypes and immunophenotypes (in routinely processed tissue). Oral Surg Oral Med Oral Pathol 1991;72: 702-8.
48. Wolvius EB, van der Valk P, van der Wal JE, van Diest PJ, Huijgens PC, van der Waal I, et al. Primary extranodal non-Hodgkin lymphoma of the oral cavity. An analysis of 34 cases. Oral Oncol 1994;30B:121-5.
49. Aster J, Kumar V. White cells, lymph nodes, spleen and thymus. In: Cotran R, Kumar V, Collins T, editors. Robbins pathologic basis of disease. 6th ed. Philadelphia: WB Saunders Company; 1999. p. 652.
50. d'Amore F, Johansen P, Houmand A, Weisenburger DD, Mortensen LS. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish lymphoma study group, LYFO. Blood 1996;87:1045-55.
51. Zhou XG, Hamilton-Dutoit SJ, Yan QH, Pallesen G. High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma. Histopathology 1994;24:115-22.
52. Borisch-Chappuis B, Nezelof C, Muller H, Muller-Hermelink HK. Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients. Am J Pathol 1990;136:751-8.
53. Swerdlow SH. Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease. Histopathology 1992;20:373-85.
54. Ioachim HL, Dorsett B, Cronin W, Maya M, Wahl S. Acquired immunodeficiency syndrome-associated lymphomas: clinical, pathologic, immunologic, and viral characteristics of 111 cases. Hum Pathol 1991;22:659-73.
55. Kristal AR, Nasca PC, Burnett WS, Mikl J. Changes in the epidemiology of non-Hodgkin's lymphoma associated with epidemic human immunodeficiency virus (HIV) infection. Am J Epidemiol 1988;128:711-8.
56. Langford A, Dienemann D, Schurman D, Pohle HD, Pauli G, Stein H, et al. Oral manifestations of AIDS-associated non-Hodgkin's lymphomas. Int J Oral Maxillofac Surg 1991;20:136-41.
57. Hicks MJ, Flaitz CM, Nichols CM, Luna MA, Gresik MV. Intraoral presentation of anaplastic large-cell Ki-1 lymphoma in association with HIV infection. Oral Surg Oral Med Oral Pathol 1993;76:73-81.
58. Delecluse HJ, Anagnostopoulous I, Dallenbach F, Hummel M, Marafioti T, Schneider U, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997;89:1413-20.
59. Gold JE, Ghali V, Gold S, Brown JC, Zalusky R. Angiocentric immunoproliferative lesion/T-cell non-Hodgkin's lymphoma and the acquired immune deficiency syndrome: a case report and review of the literature. Cancer 1990;66:2407-13.
60. Herndier BG, Shiramizu BT, Jewett NE, Aldape KD, Reyes GR, McGrath MS. Acquired immunodeficiency syndrome-associated T-cell lymphoma: evidence for human immunodeficiency virus type 1-associated T-cell transformation. Blood 1992;79: 1768-74.
61. Lust JA, Banks PM, Hooper WC, Paya CV, Kueck BD, Hanson GA, et al. T-cell non-Hodgkin lymphoma in human immunodeficiency virus-1-infected individuals. Am J Hematol 1989;31: 181-7.